Rickettsia — Rocky Mountain Spotted Fever and Others

• Vector-to-host transmission and initial infection: Infection typically occurs through the salivary glands of infected ticks (Dermacentor species, particularly Dermacentor variabilis in eastern United States and Dermacentor andersoni in western regions) as they feed for 6-24 hours on human hosts. The rickettsiae must breach the skin barrier and likely enter through the feeding lesion or through intact tick salivary gland secretions containing proteolytic enzymes. After initial cutaneous inoculation, organisms enter the bloodstream and disseminate widely within hours to days, establishing a bacteremia that persists despite immune responses. Early in infection, organisms remain relatively sequestered within endothelial cells, which explains the frequently delayed recognition of infection.

• Endothelial cell invasion and intracellular survival: Rickettsiae possess outer membrane proteins including OmpA and OmpB that facilitate adherence to host cell integrin receptors and other surface molecules, triggering receptor-mediated endocytosis. Once internalized, rickettsiae possess a phospholipase that degrades the phagolysosomal membrane, allowing escape into the cytoplasm where they replicate freely without triggering typical inflammatory responses within the infected cell. Rickettsiae encode actin-based motility proteins that allow them to move through the cytoplasm and into adjacent cells without being exposed to extracellular immune effectors, representing a key virulence strategy. The intracellular location of rickettsiae explains the relative inability of antibodies to neutralize organisms, making cell-mediated immunity critical for pathogen containment.

• Vascular endothelial inflammation and microvascular injury: The hallmark pathophysiologic consequence of rickettsial infection is rickettsial vasculitis, a widespread inflammatory process affecting small and medium-sized blood vessels. Infected endothelial cells produce increased amounts of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and upregulate surface expression of adhesion molecules (ICAM-1, VCAM-1), recruiting neutrophils and lymphocytes to infected vessels. This inflammatory infiltrate causes endothelial cell injury with increased vascular permeability and thrombosis, leading to microvascular occlusion and tissue ischemia. The vasculitis is not primarily due to direct bacterial cytotoxicity but rather results from immune recognition of infected endothelial cells by cytotoxic T lymphocytes and antibody-mediated mechanisms. This process particularly affects the skin (causing the pathognomonic rash), central nervous system, heart, lungs, and kidneys, with severity correlating with bacterial burden and the degree of endothelial involvement.

• Coagulation cascade activation and microthrombosis: Rickettsial-induced endothelial injury activates tissue factor on infected endothelial cells, triggering the extrinsic coagulation pathway and leading to disseminated intravascular coagulation (DIC) in severe cases. Platelet counts fall as platelets are consumed in microthrombi within affected tissues, particularly in the brain, lungs, and kidneys. Fibrin deposition contributes to vascular occlusion and tissue necrosis, and fibrin-platelet thrombi can be visualized in the characteristic rash of RMSF, representing pathognomonic histopathologic findings. The coagulopathy worsens with delays in antibiotic therapy, as continued bacterial replication perpetuates endothelial activation.

• Vascular permeability and shock: Widespread endothelial dysfunction and inflammatory cytokine release cause a profound increase in capillary permeability, leading to extravasation of fluid into interstitial spaces and the development of hypovolemic shock in severe cases. Hypoalbuminemia frequently develops secondary to protein loss from damaged capillaries and hepatic dysfunction. The loss of vascular integrity coupled with microvascular thrombosis creates a precarious hemodynamic state in which patients are simultaneously volume-depleted and congested, making fluid management exceptionally challenging.

• Organ-specific pathophysiology: In the central nervous system, infected endothelial cells in the brain are surrounded by inflammatory infiltrates, causing meningoencephalitis with perivascular inflammation that can lead to altered mental status, seizures, and stroke from vessel occlusion. Pulmonary involvement results from direct infection of lung endothelial cells and alveolar capillary inflammation, causing noncardiogenic pulmonary edema and acute respiratory distress syndrome (ARDS). Renal injury occurs from acute tubular necrosis secondary to hypotension and microvascular thrombosis as well as from direct infection of renal endothelium. Myocardial involvement can cause myocarditis with arrhythmias and cardiogenic shock. Cutaneous manifestations result from the inflammatory response in dermal and epidermal blood vessels, with initial vasculitis causing blanching erythematous macules that progress to petechiae as thrombosis develops.

• **Rocky Mountain spotted fever (RMSF) — *Rickettsia rickettsii***: The most severe rickettsial infection in the Americas, transmitted by hard ticks of the Dermacentor genus, with Dermacentor variabilis (American dog tick) responsible for the majority of cases in eastern and central United States and Dermacentor andersoni (Rocky Mountain wood tick) predominant in western states. Contrary to its name, RMSF is more common in the southeastern United States (North Carolina has the highest incidence), and cases are rare in the actual Rocky Mountain region. Risk increases with exposure to tick-infested areas, particularly during warm months when both tick activity and recreational outdoor exposure peak. Men have slightly higher incidence than women, likely reflecting greater occupational or recreational exposure. Patients with delayed tick removal (>24 hours) have higher infection risk because rickettsiae require extended feeding time for transmission, though some evidence suggests transmission can occur as early as 6 hours of feeding in highly infected ticks.

• **Endemic typhus — *Rickettsia typhi***: Transmitted to humans through flea bites (principally the oriental rat flea Xenopsylla cheopis) or flea feces contaminating bite wounds or abraded skin. Rats and opossums serve as the animal reservoir. Endemic typhus has a worldwide distribution with cases reported in the southern United States (Texas, California, Hawaii), tropical and subtropical regions. Risk is increased in persons with exposure to flea-infested animals or unsanitary living conditions. Endemic typhus is significantly milder than RMSF, with lower mortality rates and less severe systemic disease.

• **Epidemic typhus — *Rickettsia prowazekii***: Transmitted by the human body louse (Pediculus humanus humanus), with humans as the only reservoir, making this disease associated with crowded living conditions, poverty, homelessness, and wars. Epidemic typhus historically caused massive mortality during wartime (particularly World War II), famines, and in refugee camps. Current cases in the United States are rare and sporadic, typically associated with homelessness or louse-infested shelters. Secondary cases of epidemic typhus can occur years to decades after primary infection when rickettsiae reactivate from latently infected endothelial cells, a phenomenon called Brill-Zinsser disease, which presents with milder clinical disease than primary infection.

• **Scrub typhus — *Orientia tsutsugamushi***: Transmitted by mites (Leptotrombidium species) in the "tsutsugamushi triangle" spanning from northern Japan and southeastern Russia south to northern Australia, and from Pakistan east to the Pacific Islands. This is the most common rickettsial infection worldwide with over 1 million cases annually, particularly affecting agricultural workers and hikers in endemic regions. Risk correlates with exposure to mite-infested vegetation, particularly during rainy seasons when mite populations peak. Human cases are incidental hosts; transmission occurs through mite larval stages.

• Other rickettsial infections: Mediterranean spotted fever (African tick-bite fever, Rickettsia africae) and Asian spotted fever (Rickettsia japonica) are emerging infections transmitted by Amblyomma ticks in specific geographic regions. Rickettsial pox (Rickettsia akari) is transmitted by mites parasitizing house mice and causes mild disease in urban settings.

• Fever and systemic toxicity: Fever is nearly universal, typically developing 2-14 days after tick exposure (mean 7 days) and persisting for 2-3 weeks if untreated. The fever is characteristically high (often >39.5°C [103.1°F]) and accompanied by profound malaise, myalgias, and arthralgias affecting large joints and muscles. Patients often report severe headache (occurring in >90% of cases), which is typically frontal or retro-orbital and distinguishes rickettsial disease from many viral exanthems. The headache in RMSF is notoriously severe and may be accompanied by photophobia, creating diagnostic confusion with meningitis.

• Rash (pathognomonic feature): The maculopapular rash appears in 80-90% of RMSF cases, typically emerging 3-5 days after fever onset (though it may appear as late as day 8-9, or rarely not at all, creating diagnostic delay). The rash classically begins on the wrists and ankles as small pink blanching macules and spreads centripetally (inward) over 1-3 days toward the trunk and face—a pattern that helps distinguish it from other infectious exanthems. The rash progresses from blanching macules to nonblanching petechiae (reflecting the microvascular thrombosis and endothelial dysfunction), and lesions may become hemorrhagic and necrotic in severe cases. The "petechial rash on palms and soles" is a classic board buzzword, though this finding is present in only 50-80% of cases and may appear late in illness. The rash may involve mucous membranes (enanthem). Approximately 10-20% of RMSF cases lack rash entirely, a presentation called "spotless Rocky Mountain spotted fever" that carries worse prognosis because diagnostic delay is more common. Patients with darker skin tones may have delayed rash recognition due to difficulty visualizing erythema, contributing to worse outcomes in these populations—a critical equity consideration for clinicians.

• Headache, meningismus, and central nervous system manifestations: Headache is often the most prominent feature and may be accompanied by neck stiffness, photophobia, and altered mental status, mirroring bacterial meningitis and creating diagnostic challenges. Frank meningoencephalitis occurs in 10-30% of cases, with cerebrospinal fluid (CSF) showing pleocytosis (typically lymphocytic, though early cases may have neutrophilic predominance) with moderately elevated protein and normal or low glucose. Patients may experience seizures, stroke from vasculitis-induced thrombosis or hypotension, coma, and permanent neurologic sequelae in survivors. The vasculitis affecting the brain creates a distinctive meningoencephalitis pattern that differs from bacterial meningitis in the relative mildness of CSF changes and lack of organism visualization on Gram stain.

• Respiratory symptoms and pulmonary manifestations: Cough, dyspnea, and chest pain occur in 10-40% of cases and may progress to severe respiratory compromise. Chest radiography may reveal bilateral infiltrates consistent with noncardiogenic pulmonary edema or acute respiratory distress syndrome (ARDS), which develops in 5-10% of cases and represents a leading cause of mortality in RMSF. The pulmonary edema reflects the widespread increase in capillary permeability from endothelial inflammation rather than cardiac dysfunction.

• Abdominal manifestations: Nausea, vomiting, abdominal pain, and diarrhea occur in 20-40% of cases. Abdominal pain may be severe, leading to concern for surgical abdomies, though the abdomen is typically soft on examination without peritoneal signs. Some patients develop hepatitis with elevated liver enzymes and hyperbilirubinemia. Pancreatitis has been reported in severe cases.

• Renal involvement: Acute kidney injury occurs in 20-50% of cases, ranging from mild elevations in creatinine to fulminant renal failure requiring dialysis. The renal dysfunction results from a combination of prerenal azotemia secondary to hypovolemia and acute tubular necrosis from direct infection of renal endothelium and microvascular thrombosis.

• Cardiovascular manifestations: Myocarditis with arrhythmias, shock from profound hypovolemia and microvascular dysfunction, and hypotension refractory to fluid resuscitation characterize severe disease. The shock state in RMSF is unique because patients are simultaneously volume-depleted from capillary leak and fluid-overloaded in the pulmonary and cerebral compartments, making fluid management extraordinarily challenging.

• Physical examination findings: Petechial rash on palms and soles (classic but not sensitive), eschar (a necrotic lesion at the tick bite site) is particularly prominent in scrub typhus and Mediterranean spotted fever but may be inconspicuous or absent in RMSF, splenomegaly (25-50% of cases), hepatomegaly, conjunctival injection without exudate (common), petechiae on conjunctivae, and edema (reflecting the widespread capillary leak and hypoproteinemia).

• Important clinical variants: Spotless RMSF (absence of rash in 10-20% of cases) represents a major diagnostic trap associated with worse outcomes due to delayed recognition. Fulminant RMSF develops when diagnosis is delayed beyond 5-7 days of illness, with mortality rates >30% despite treatment, manifesting with profound shock, DIC, ARDS, and multi-organ failure. Mild rickettsial infections (endemic typhus, Mediterranean spotted fever) present with lower fever, less severe systemic symptoms, and excellent prognosis with treatment.

• Clinical diagnosis and high index of suspicion: Diagnosis of rickettsial infection must be primarily clinical in the acute phase, as confirmatory serologic tests are not reliable during the first week of illness when treatment decisions must be made. Any patient presenting with the triad of fever, headache, and rash (particularly petechial rash on palms and soles) during tick season (April-September in North America) should be treated empirically for RMSF without awaiting confirmatory testing. The classic teaching is that empiric therapy should never be delayed for diagnostic confirmation because early treatment dramatically reduces mortality (from >20% to <5%), whereas delays of even a few days significantly worsen outcomes. Geographic and seasonal context is critical—summer illness in tick-endemic areas (southeastern United States for RMSF, rural areas for endemic typhus) should raise suspicion.

• Serologic testing (antibody detection): IgM and IgG antibodies appear relatively late, typically becoming detectable by day 7-10 of illness, making acute-phase serology unreliable for guiding initial treatment. The indirect fluorescent antibody (IFA) test is the gold standard for serologic confirmation, demonstrating fourfold or greater rise in titers between acute and convalescent sera (collected 2-4 weeks apart). A single IFA titer of ≥1:64 or ≥1:128 (depending on local epidemiology) is considered positive in the appropriate clinical context. Sensitivity of IFA is approximately 95% by 2-3 weeks of illness, but only 50% in the first week, confirming the unreliability of acute serology

Immediate priorities

• Empiric therapy before confirmation: Per the CDC's Diagnosis and Management of Tickborne Rickettsial Diseases recommendations, treatment is started on clinical suspicion alone; mortality rises sharply when doxycycline is begun after day 5 of illness. Serology must never gate the first dose.
• Supportive care: ICU-level monitoring for hypotension, hypoxemia, and encephalopathy. Fluid resuscitation is titrated cautiously — the same capillary leak that causes hypovolemia also predisposes to noncardiogenic pulmonary and cerebral edema, so volume is given to perfusion endpoints with early vasopressor support rather than by large fixed boluses.

First-line therapy

• Tetracyclines — doxycycline: The drug of choice for all rickettsioses (spotted fever group, typhus group, scrub typhus) and at every age. Adults and children weighing ≥45 kg receive 100 mg PO/IV twice daily; children weighing <45 kg receive 2.2 mg/kg PO/IV twice daily (maximum 100 mg per dose). It is bacteriostatic against an obligate intracellular organism, so host cell-mediated immunity finishes the job — clinical defervescence within 24–48 hours is expected and is itself supportive evidence for the diagnosis. Continue at least 3 days after the patient is afebrile, for a minimum course of about 5–7 days.
• Children under 8 years: The AAP Red Book and CDC both endorse doxycycline for suspected rickettsial disease at any age; short courses have not been shown to stain permanent teeth. Withholding it for age is a management error, not caution.

Alternatives and special situations

• Chloramphenicol: Historically the alternative for severe doxycycline allergy or pregnancy, but it is associated with higher RMSF case-fatality and is not available orally in the US. CDC guidance favors doxycycline even in pregnancy when life-threatening RMSF is suspected.
• Macrolides — azithromycin: An accepted alternative for scrub typhus (including in pregnancy and where doxycycline-tolerant strains have been reported) and for mild spotted fever group illness in pregnancy, though doxycycline remains preferred for scrub typhus in most settings. Azithromycin is not adequate for severe or suspected RMSF, where doxycycline is first-line regardless.

Contraindicated / ineffective

• Sulfonamides (TMP-SMX): May worsen rickettsial illness — a classic exam trap.
• Beta-lactams and aminoglycosides: No activity; the organism replicates free in host cytoplasm.
• No post-exposure prophylaxis is recommended after a tick bite for RMSF, unlike single-dose doxycycline for high-risk Ixodes bites in Lyme-endemic areas.

Emergencies — recognize immediately

• Fulminant RMSF with septic shock: Widespread endothelial injury and capillary leak produce vasodilatory plus hypovolemic shock refractory to fluids. Signaled by hypotension with rising lactate, anasarca, and profound hypoalbuminemia. Associated with diagnostic delay beyond day 5 and, classically, with G6PD deficiency in males.
• ARDS / noncardiogenic pulmonary edema: Alveolar–capillary endothelial infection causes permeability edema. Signaled by worsening hypoxemia with bilateral infiltrates and a normal cardiac silhouette — often precipitated by over-aggressive fluid resuscitation.
• Meningoencephalitis and cerebral edema: Perivascular inflammation plus microthrombosis. Signaled by confusion, seizure, focal deficit, or coma with a modest lymphocytic CSF pleocytosis and a negative Gram stain — the CSF picture is far milder than the clinical state, which is the diagnostic clue.
• DIC: Endothelial tissue factor expression drives consumptive coagulopathy. Signaled by falling platelets, prolonged PT/aPTT, low fibrinogen, elevated D-dimer, and spreading purpura.

Organ-specific

• Acute kidney injury: Prerenal azotemia plus ATN from microvascular thrombosis; rising creatinine with oliguria, occasionally requiring dialysis.
• Myocarditis and arrhythmia: Troponin elevation, new heart failure, or conduction disturbance.
• Peripheral gangrene: Digit, ear, or limb necrosis from occlusive vasculitis; may require amputation.
• Late sequelae in survivors: Sensorineural hearing loss, cognitive impairment, spasticity, and paraparesis after severe encephalitis.

Treatment-related

• Doxycycline: Pill esophagitis (mitigated by upright dosing with water), photosensitivity, GI intolerance, and rarely benign intracranial hypertension. Dental staining is a theoretical concern with prolonged repeated courses, not short therapeutic ones.
• Chloramphenicol: Dose-dependent reversible marrow suppression and idiosyncratic aplastic anemia; gray baby syndrome in neonates from immature glucuronidation.
• Sulfonamide exposure: Not a drug toxicity but a therapeutic misstep — clinical deterioration after TMP-SMX should prompt reconsideration of rickettsial disease.

• The single best next step is doxycycline, empirically: Any febrile patient with headache and a rash on the wrists/ankles in tick season gets doxycycline now. "Send IFA serology and await results" and "await convalescent titers" are always wrong answers in the acute stem.
• Doxycycline in children of any age: The AAP Red Book endorses it for suspected rickettsial disease under age 8. The distractor is switching to chloramphenicol "because of the teeth" — chloramphenicol carries higher RMSF mortality and risks aplastic anemia.
• Direction of rash spread is the discriminator: RMSF is centripetal (peripheral wrists/ankles/palms/soles moving inward). Typhus group spreads centrifugally from the trunk outward and characteristically spares palms and soles.
• Eschar biology: An eschar at the bite site points to scrub typhus, African tick-bite fever, or rickettsialpox — it is typically absent in RMSF. Rickettsialpox gives a papulovesicular "chickenpox-like" rash after a mouse-mite bite.
• Labs that fit: Thrombocytopenia, hyponatremia, transaminitis, with a normal or low WBC. A high white count argues against RMSF and toward a bacterial mimic like meningococcemia.
• The classic distractors are ehrlichiosis and anaplasmosis — and they are not the same organism or vector:
• **Ehrlichiosis (Ehrlichia chaffeensis)**: Lone Star tick (Amblyomma americanum), morulae in monocytes, southeastern/south-central US.
• **Anaplasmosis (Anaplasma phagocytophilum)**: Ixodes scapularis (the same vector as Lyme disease and babesiosis), morulae in granulocytes/neutrophils, upper Midwest and Northeast.
• Both share leukopenia, thrombocytopenia, and transaminitis with usually no rash ("Rocky Mountain spotless fever"), and both are treated with doxycycline — so the question hinges on the vector, geography, and which cell line holds the morulae, not on the therapy.
• Weil-Felix is obsolete but examinable: Cross-reacting Proteus OX-19/OX-2 agglutination in spotted fever and typhus groups, OX-K in scrub typhus, negative in rickettsialpox and in Coxiella (Q fever, which has no rash and no arthropod bite required).
• Never sulfonamides: TMP-SMX can worsen rickettsial disease; beta-lactams are useless against a cytoplasmic obligate intracellular organism.
• Brill-Zinsser disease is recrudescent R. prowazekii years after primary epidemic typhus — milder, and the reservoir for new louse-borne outbreaks.